McMaster University launches first online training on bleeding disorders in
Canada
New continuing education program launched through machealth.ca website
HAMILTON, ON,
The program, located at www.eHemophilia.ca, was developed by the Division of e-Learning Innovation of the Michael G. DeGroote School of Medicine and leading Canadian specialists in bleeding disorders in emergency medicine, pediatrics, and hematology. The program is relevant to family physicians and other health care personnel working in emergency medicine, as well as medical students and residents. It has been accredited by McMaster's Continuing Health Sciences Education program for both family physicians and specialists for professional development credits.
"Our eHemophilia.ca program demonstrates McMaster's continued commitment to educating healthcare professionals and ultimately improving care for all Canadians," said
"The eHemophilia.ca program is an unique and important tool to educate healthcare professionals who want to be aware of the most current information and treatment options about bleeding disorders. As the program is online and can be viewed globally, this will really show Canada's leadership in this area," added
The content of eHemophilia.ca will help a variety of health care professionals to best manage patients with congenital and acquired bleeding disorders, adopt a simplified approach to patients suspected of having bleeding disorders, and review treatment guidelines to rapidly restore homeostasis in the emergency setting.
The eHemophilia.ca program also provides professionals with first-hand patient cases and interactive animations allowing them to expand their knowledge and understanding about bleeding disorders by engaging them in the diagnosis and treatment process.
"The Canadian Hemophilia Society recognizes the importance of this e-learning tool and its ability to further educate professionals about managing bleeding disorders and the Society's Factor First guidelines program," said
"With the launch of the eHemophilia.ca program, Bayer continues to expand on its commitment to Canada's bleeding disorders community," said
One in 100 Canadians carry an inherited bleeding disorder gene, and 1 in 10 of these, or 35,000 Canadians, have symptoms severe enough to require medical care.
"Bleeding disorders, such as hemophilia, are quite rare in
For further information: Veronica McGuire, Media Relations, Faculty of Health Sciences, McMaster University, (905) 525-9140, ext. 22169, [email protected]; Tiana DiMichele, Business Communications Partner, Bayer Inc., (416) 240-5240, [email protected]; Collin Matanowitsch, MS&L, (416) 847-1330, [email protected]
Share this article